Skip to main content
Log in

In Vitro Evaluation of Insulin Release from Chitosan-Alginate Macrobeads

  • Original Article
  • Published:
Journal of Pharmaceutical Innovation Aims and scope Submit manuscript

Abstract

Purpose

Oral delivery of peptide/protein is quite difficult due to physiological barriers. Encapsulation of these drugs in the suitable biopolymeric matrix could protect the drug as well as increase the residence time of the formulation. Mucoadhesive biopolymers are being widely investigated for this purpose.

Methods

We have fabricated insulin-loaded chemically crosslinked chitosan-alginate macrobeads of approximate size 3 mm per bead. The beads were characterized for surface morphology and polymeric interaction using SEM, EDX, and FTIR, respectively.

Results

The swelling profile and insulin release were analyzed in water and PBS for 9 h. The surface had uniform undulations as observed by SEM. EDX confirmed the chemical crosslinking of chitosan and alginate. FTIR further confirmed the interaction among the polymers. The swelling study revealed a gradual increase for some time and then a decrease in weight possibly due to the disintegration of beads. A cumulative release of approximately 35% was observed by the end of 9 h in both the dissolution medium.

Conclusions

This work is done to investigate the possibility of release of protein/peptide drugs from polysaccharide biopolymer-based blended hydrogel matrix for possible non-invasive delivery of such drugs orally. Here, we have formulated mixed polyelectrolyte hydrogel beads of chitosan and alginate encapsulating insulin as the model drug. Our work shows a sustained release of insulin from the chitosan-alginate beads.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Richard J. Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects. Ther Deliv. 2017;8(8):663–84.

    Article  CAS  Google Scholar 

  2. Lundquist P, Artursson P. Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations and studies in human tissues. Adv Drug Deliv Rev. 2016;106(Pt B):256–76.

    Article  CAS  Google Scholar 

  3. Yun YH, Lee BK, Park K. Controlled drug delivery: historical perspective for the next generation. J Control Release. 2015;219:2–7.

    Article  CAS  Google Scholar 

  4. Vilar G, Tulla-Puche J, Albericio F. Polymers and drug delivery systems. Curr Drug Deliv. 2012;9(4):367–94.

    Article  CAS  Google Scholar 

  5. Kumar A, Vimal A, Kumar A. Why chitosan? From properties to perspective of mucosal drug delivery. Int J Biol Macromol. 2016;91:615–22.

    Article  CAS  Google Scholar 

  6. Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci. 2012;37(1):106–26.

    Article  CAS  Google Scholar 

  7. Kumar A, Bharti SK, Kumar A. Therapeutic molecules against type 2 diabetes: What we have and what are we expecting? Pharmacol Rep. 2017;69(5):959–70.

    Article  CAS  Google Scholar 

  8. Takka S, Gürel A. Evaluation of chitosan/alginate beads using experimental design: formulation and in vitro characterization. AAPS PharmSciTech. 2010;11(1):460–6.

    Article  CAS  Google Scholar 

  9. WHO expert committee on biological standardization (2010) http://www.who.int/biologicals/expert_committee/BS_2143_Human_Recombinant_Insulin_final.pdf. Accessed 11 Jan 2019.

  10. Arbit E, Kidron M. Oral insulin delivery in a physiologic context: review. J Diabetes Sci Technol. 2017;11(4):825–32.

    Article  CAS  Google Scholar 

  11. Accessed from https://clinicaltrials.gov/ct2/show/NCT03430856. Accessed 6 January 2021.

  12. Khedkar A, Lebovitz H, Fleming A, Cherrington A, Jose V, Athalye SN, Vishweswaramurthy A. Pharmacokinetics and pharmacodynamics of insulin tregopil in relation to premeal dosing time, between meal interval, and meal composition in patients with type 2 diabetes mellitus. Clin Pharmacol Drug Dev. 2020;9(1):74–86.

    Article  CAS  Google Scholar 

  13. Hu Y, Peng J, Ke L, Zhao D, Zhao H, Xiao X. Alginate/carboxymethyl chitosan composite gel beads for oral drug delivery. J Polym Res. 2016;23:129.

    Article  Google Scholar 

  14. Hari PR, Chandy T, Sharma CP. Chitosan/calcium-alginate beads for oral delivery of insulin. J Applied Polym Sci. 1996;59:1795–801.

    Article  CAS  Google Scholar 

  15. van der Merwe SM, Verhoef JC, Verheijden JHM, Kotze AF, Junginger HE. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm. 2004;58:225–35.

    Article  Google Scholar 

  16. Dunnhaupt S, Barthelmes J, Rahmat D, Leithner K, Thurner CC, Friedl H, et al. S-Protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties. Mol Pharmaceutics. 2012;9:1331–41.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Awanish Kumar.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kumar, A., Thakur, P. & Kumar, A. In Vitro Evaluation of Insulin Release from Chitosan-Alginate Macrobeads. J Pharm Innov 17, 546–554 (2022). https://doi.org/10.1007/s12247-021-09534-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12247-021-09534-9

Keywords

Navigation